Analyses stratified according to baseline cirrhosis status showed an association of IFNL4 genotype with HCC progression in patients with cirrhosis (OR=2.32, p=0.019, Table 4) but not without cirrhosis (OR=1.80, p=0.055, Table 4), although this association was eliminated after adjusting for SVR. This evidence concerns the gene IFNL4 and hepatocellular carcinoma.